News

The application was based on a study showing that the deltoid and gluteal injections of Risperdal Consta were bioequivalent routes of administration and thus interchangeable. An additional study

The new NimbleGen comparative genomic hybridization (CGH) HD2 arrays follow on the heals of Roche NimbleGen’s recent launch of CGH 4x72K arrays, aimed at improving sample throughput for

Pathway Medical Technologies co-founder and previous CEO Tom Clement, who has been instrumental in leading the company through the initial stages to commercialization, will continue as an officer

In this role, Ms McCoy succeeds Christine Poon, who announced plans to retire from the company on March 1, 2009. Ms McCoy joined Johnson & Johnson (J&J) in

Under the purchase agreement, Natus will acquire essentially all the trading assets of BrainZ for a cash price of NZD$1.3 million, including the BRM2 and BRM3 monitoring devices,

Under the agreement, Itochu Chemical Frontier (ICF) will supply injectable products for which Sagent will obtain the US regulatory approval and market them in the US. Jeffrey Yordon,

The LBI embolectomy system consists of a 0.014” guide wire containing a three-dimensional fiber-based element used in combination with the previously cleared Xtract aspiration catheter. The expandable element

The company expects to report top-line results from this pivotal trial in November 2008. Ibuprofen is an analgesic that is sold in immediate-dose products as Advil and Motrin,

Additional participants include existing investors Aphelion Capital, California Technology Ventures and a group of accredited private individuals. Carter McNabb, managing director of River Cities Capital Funds has joined